| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Unfolded Protein Response | 5 | 2021 | 134 | 2.95 | Why? |
| Autophagy | 10 | 2021 | 960 | 2.81 | Why? |
| Glioblastoma | 5 | 2019 | 187 | 1.62 | Why? |
| Mevalonic Acid | 2 | 2017 | 24 | 1.34 | Why? |
| Transforming Growth Factor beta1 | 2 | 2018 | 204 | 1.24 | Why? |
| Epithelial-Mesenchymal Transition | 2 | 2019 | 242 | 1.21 | Why? |
| Toll-Like Receptor 4 | 2 | 2019 | 390 | 1.13 | Why? |
| Drug Resistance, Neoplasm | 2 | 2018 | 447 | 1.09 | Why? |
| RNA, Long Noncoding | 2 | 2018 | 408 | 1.01 | Why? |
| Genetic Predisposition to Disease | 8 | 2021 | 4027 | 0.98 | Why? |
| rho GTP-Binding Proteins | 2 | 2018 | 18 | 0.95 | Why? |
| Ionophores | 1 | 2020 | 60 | 0.83 | Why? |
| Apoptosis | 6 | 2017 | 2335 | 0.81 | Why? |
| 3' Untranslated Regions | 2 | 2018 | 318 | 0.81 | Why? |
| Resistin | 1 | 2018 | 16 | 0.77 | Why? |
| Guanosine Triphosphate | 1 | 2018 | 29 | 0.77 | Why? |
| Carcinoma, Non-Small-Cell Lung | 2 | 2019 | 896 | 0.76 | Why? |
| Chemistry Techniques, Analytical | 1 | 2018 | 42 | 0.74 | Why? |
| Genetic Association Studies | 3 | 2019 | 559 | 0.73 | Why? |
| Neuropilin-1 | 1 | 2021 | 284 | 0.72 | Why? |
| Hyaluronan Receptors | 1 | 2018 | 61 | 0.71 | Why? |
| Interleukin-1alpha | 1 | 2017 | 42 | 0.71 | Why? |
| Polymorphism, Restriction Fragment Length | 1 | 2018 | 116 | 0.71 | Why? |
| Autophagy-Related Proteins | 1 | 2019 | 157 | 0.70 | Why? |
| INDEL Mutation | 1 | 2018 | 128 | 0.69 | Why? |
| DNA-Directed RNA Polymerases | 1 | 2018 | 239 | 0.68 | Why? |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2018 | 1510 | 0.68 | Why? |
| Quercetin | 1 | 2020 | 297 | 0.68 | Why? |
| Simvastatin | 1 | 2017 | 63 | 0.67 | Why? |
| Endoplasmic Reticulum | 1 | 2020 | 430 | 0.66 | Why? |
| Farnesyltranstransferase | 2 | 2017 | 8 | 0.66 | Why? |
| Alkyl and Aryl Transferases | 2 | 2017 | 22 | 0.65 | Why? |
| Cell Membrane | 2 | 2018 | 743 | 0.63 | Why? |
| Intracellular Signaling Peptides and Proteins | 1 | 2018 | 334 | 0.60 | Why? |
| Signal Transduction | 10 | 2021 | 7207 | 0.60 | Why? |
| Prostatic Neoplasms | 2 | 2018 | 1637 | 0.59 | Why? |
| Protein Processing, Post-Translational | 1 | 2018 | 634 | 0.58 | Why? |
| Metabolic Networks and Pathways | 1 | 2017 | 285 | 0.58 | Why? |
| Disease | 1 | 2017 | 126 | 0.57 | Why? |
| alpha 1-Antitrypsin | 2 | 2009 | 264 | 0.57 | Why? |
| Peptide Library | 1 | 2018 | 564 | 0.56 | Why? |
| Trace Elements | 1 | 2018 | 284 | 0.56 | Why? |
| Endoplasmic Reticulum Stress | 1 | 2017 | 253 | 0.56 | Why? |
| Graphite | 1 | 2018 | 318 | 0.55 | Why? |
| Polymorphism, Single Nucleotide | 6 | 2019 | 3607 | 0.54 | Why? |
| Neoplastic Stem Cells | 4 | 2019 | 120 | 0.53 | Why? |
| Neoplasm Proteins | 2 | 2018 | 501 | 0.52 | Why? |
| Fibroblasts | 1 | 2017 | 839 | 0.51 | Why? |
| Colonic Neoplasms | 1 | 2017 | 295 | 0.49 | Why? |
| Alveolar Epithelial Cells | 1 | 2020 | 1445 | 0.47 | Why? |
| Polymorphism, Genetic | 2 | 2018 | 1074 | 0.46 | Why? |
| Antitubercular Agents | 1 | 2018 | 775 | 0.45 | Why? |
| Urinary Bladder Neoplasms | 1 | 2018 | 614 | 0.44 | Why? |
| Cell Line, Tumor | 6 | 2019 | 3608 | 0.43 | Why? |
| Inflammasomes | 1 | 2017 | 710 | 0.43 | Why? |
| Myocytes, Smooth Muscle | 1 | 2011 | 127 | 0.42 | Why? |
| Idiopathic Pulmonary Fibrosis | 1 | 2017 | 595 | 0.42 | Why? |
| Single-Domain Antibodies | 1 | 2018 | 744 | 0.42 | Why? |
| Brain Neoplasms | 1 | 2017 | 669 | 0.42 | Why? |
| Mycobacterium tuberculosis | 1 | 2019 | 1164 | 0.39 | Why? |
| Influenza A virus | 1 | 2020 | 2234 | 0.36 | Why? |
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 1573 | 0.36 | Why? |
| Tuberculosis, Pulmonary | 1 | 2018 | 1171 | 0.34 | Why? |
| Endosomes | 2 | 2021 | 490 | 0.33 | Why? |
| Carcinoma, Hepatocellular | 1 | 2017 | 1222 | 0.33 | Why? |
| Matrix Metalloproteinase 1 | 1 | 2007 | 60 | 0.33 | Why? |
| Conjunctivitis, Allergic | 1 | 2007 | 94 | 0.30 | Why? |
| Matrix Metalloproteinase 9 | 1 | 2007 | 211 | 0.30 | Why? |
| Iran | 4 | 2018 | 5467 | 0.29 | Why? |
| Breast Neoplasms | 3 | 2019 | 3633 | 0.29 | Why? |
| Antineoplastic Agents | 2 | 2019 | 3550 | 0.29 | Why? |
| Liver Neoplasms | 1 | 2017 | 1666 | 0.28 | Why? |
| Lung Neoplasms | 2 | 2019 | 3228 | 0.28 | Why? |
| Bronchi | 1 | 2011 | 1048 | 0.28 | Why? |
| Enzyme-Linked Immunosorbent Assay | 2 | 2018 | 7868 | 0.28 | Why? |
| Drug Carriers | 2 | 2021 | 590 | 0.27 | Why? |
| Genotype | 4 | 2019 | 4697 | 0.25 | Why? |
| Tears | 1 | 2007 | 400 | 0.25 | Why? |
| Colorectal Neoplasms | 1 | 2017 | 1884 | 0.25 | Why? |
| Serine Proteinase Inhibitors | 1 | 2007 | 341 | 0.25 | Why? |
| Tuberculosis | 1 | 2019 | 2895 | 0.25 | Why? |
| Case-Control Studies | 7 | 2019 | 17671 | 0.24 | Why? |
| A549 Cells | 2 | 2019 | 2066 | 0.23 | Why? |
| Cell Proliferation | 3 | 2019 | 1973 | 0.23 | Why? |
| Acetazolamide | 1 | 2020 | 27 | 0.21 | Why? |
| Clathrin-Coated Vesicles | 1 | 2020 | 36 | 0.21 | Why? |
| Carbonic Anhydrase Inhibitors | 1 | 2020 | 31 | 0.21 | Why? |
| Molecular Chaperones | 1 | 2021 | 124 | 0.21 | Why? |
| Flap Endonucleases | 1 | 2019 | 7 | 0.20 | Why? |
| Cell Survival | 2 | 2019 | 1581 | 0.20 | Why? |
| Prenylation | 1 | 2018 | 3 | 0.20 | Why? |
| Neoplasms | 5 | 2019 | 17251 | 0.20 | Why? |
| Humans | 50 | 2021 | 930598 | 0.19 | Why? |
| Oncogene Proteins | 1 | 2018 | 17 | 0.19 | Why? |
| Spectrophotometry, Atomic | 1 | 2018 | 11 | 0.19 | Why? |
| Bromhexine | 1 | 2020 | 120 | 0.19 | Why? |
| ral GTP-Binding Proteins | 1 | 2017 | 1 | 0.18 | Why? |
| Tretinoin | 1 | 2019 | 99 | 0.18 | Why? |
| Host-Pathogen Interactions | 1 | 2019 | 11041 | 0.18 | Why? |
| NLR Proteins | 1 | 2017 | 23 | 0.18 | Why? |
| Cell Death | 2 | 2019 | 536 | 0.18 | Why? |
| Gyrovirus | 1 | 2017 | 2 | 0.18 | Why? |
| Chicken anemia virus | 1 | 2017 | 5 | 0.18 | Why? |
| Collagen Type I | 1 | 2017 | 56 | 0.18 | Why? |
| Vimentin | 1 | 2018 | 86 | 0.17 | Why? |
| Arsenic | 1 | 2018 | 85 | 0.17 | Why? |
| Dacarbazine | 1 | 2017 | 67 | 0.17 | Why? |
| Cadherins | 1 | 2018 | 145 | 0.17 | Why? |
| Cell Fractionation | 1 | 2016 | 44 | 0.17 | Why? |
| Hydrogels | 1 | 2019 | 173 | 0.17 | Why? |
| Cell Transdifferentiation | 1 | 2017 | 47 | 0.17 | Why? |
| Circoviridae Infections | 1 | 2017 | 42 | 0.17 | Why? |
| Caspase 1 | 1 | 2017 | 149 | 0.17 | Why? |
| Haplotypes | 2 | 2019 | 853 | 0.17 | Why? |
| Cellular Reprogramming Techniques | 1 | 2017 | 43 | 0.17 | Why? |
| Fibronectins | 1 | 2017 | 92 | 0.17 | Why? |
| Endocytosis | 1 | 2020 | 451 | 0.16 | Why? |
| Gene Expression Regulation, Neoplastic | 3 | 2018 | 1014 | 0.16 | Why? |
| Regenerative Medicine | 1 | 2018 | 161 | 0.16 | Why? |
| Nanomedicine | 1 | 2021 | 329 | 0.16 | Why? |
| Tissue Engineering | 1 | 2018 | 190 | 0.16 | Why? |
| Apoptosis Regulatory Proteins | 1 | 2017 | 202 | 0.16 | Why? |
| Hyaluronic Acid | 1 | 2018 | 168 | 0.16 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2017 | 6166 | 0.16 | Why? |
| PTEN Phosphohydrolase | 1 | 2016 | 70 | 0.16 | Why? |
| Terpenes | 1 | 2017 | 135 | 0.16 | Why? |
| Cellular Reprogramming | 1 | 2017 | 117 | 0.15 | Why? |
| Cell Cycle | 1 | 2017 | 329 | 0.15 | Why? |
| Influenza, Human | 1 | 2020 | 10779 | 0.15 | Why? |
| Alleles | 2 | 2019 | 1557 | 0.15 | Why? |
| Genetic Therapy | 1 | 2020 | 409 | 0.15 | Why? |
| Quinolones | 1 | 2017 | 167 | 0.15 | Why? |
| RNA, Small Interfering | 1 | 2020 | 817 | 0.15 | Why? |
| Taste | 1 | 2021 | 715 | 0.15 | Why? |
| Hepatitis, Autoimmune | 1 | 2020 | 254 | 0.15 | Why? |
| Interleukin-18 | 1 | 2017 | 328 | 0.15 | Why? |
| Protein Transport | 1 | 2017 | 487 | 0.15 | Why? |
| Copper | 1 | 2018 | 288 | 0.14 | Why? |
| Arabs | 1 | 2017 | 298 | 0.14 | Why? |
| Microfluidic Analytical Techniques | 1 | 2016 | 254 | 0.14 | Why? |
| Macrolides | 1 | 2018 | 369 | 0.14 | Why? |
| MicroRNAs | 2 | 2019 | 1787 | 0.14 | Why? |
| Benzimidazoles | 1 | 2017 | 275 | 0.14 | Why? |
| Capsid Proteins | 1 | 2017 | 365 | 0.13 | Why? |
| Cell Cycle Proteins | 1 | 2016 | 297 | 0.13 | Why? |
| Adaptor Proteins, Signal Transducing | 1 | 2017 | 502 | 0.13 | Why? |
| Gastrointestinal Neoplasms | 1 | 2019 | 392 | 0.13 | Why? |
| Cell Nucleus | 1 | 2016 | 399 | 0.13 | Why? |
| Proto-Oncogene Proteins c-akt | 1 | 2016 | 372 | 0.13 | Why? |
| Selenium | 1 | 2018 | 412 | 0.13 | Why? |
| Animals | 11 | 2020 | 78931 | 0.13 | Why? |
| Calcium | 1 | 2018 | 708 | 0.12 | Why? |
| Kidney Failure, Chronic | 1 | 2009 | 3222 | 0.12 | Why? |
| Printing, Three-Dimensional | 1 | 2019 | 624 | 0.12 | Why? |
| Cholesterol | 1 | 2017 | 660 | 0.12 | Why? |
| Antibody Affinity | 1 | 2018 | 1078 | 0.12 | Why? |
| Cell Differentiation | 1 | 2019 | 1338 | 0.12 | Why? |
| Iron | 1 | 2018 | 619 | 0.12 | Why? |
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2017 | 581 | 0.12 | Why? |
| Toluene | 1 | 2011 | 21 | 0.12 | Why? |
| Disease Outbreaks | 1 | 2020 | 27595 | 0.12 | Why? |
| Interleukin-1beta | 1 | 2017 | 992 | 0.12 | Why? |
| Antimalarials | 2 | 2021 | 2505 | 0.11 | Why? |
| Benzothiazoles | 1 | 2011 | 128 | 0.11 | Why? |
| Drug Approval | 1 | 2020 | 1325 | 0.11 | Why? |
| T-Lymphocytes, Regulatory | 1 | 2017 | 698 | 0.11 | Why? |
| Models, Biological | 2 | 2018 | 4907 | 0.11 | Why? |
| Zinc | 1 | 2018 | 817 | 0.11 | Why? |
| Primary Cell Culture | 1 | 2011 | 501 | 0.10 | Why? |
| Escherichia coli | 1 | 2018 | 1547 | 0.10 | Why? |
| Odds Ratio | 2 | 2019 | 5861 | 0.10 | Why? |
| Extracellular Vesicles | 1 | 2016 | 607 | 0.10 | Why? |
| Methionine | 1 | 2009 | 53 | 0.10 | Why? |
| Immunity, Innate | 2 | 2019 | 6570 | 0.10 | Why? |
| Tumor Suppressor Protein p53 | 1 | 2011 | 310 | 0.10 | Why? |
| Benzamides | 1 | 2011 | 421 | 0.09 | Why? |
| Viral Envelope Proteins | 1 | 2021 | 3539 | 0.09 | Why? |
| Lung | 1 | 2017 | 31049 | 0.09 | Why? |
| Delivery of Health Care, Integrated | 1 | 2020 | 1549 | 0.09 | Why? |
| Membrane Proteins | 1 | 2018 | 1733 | 0.09 | Why? |
| Antiviral Agents | 4 | 2021 | 41703 | 0.09 | Why? |
| Dose-Response Relationship, Drug | 1 | 2017 | 3776 | 0.08 | Why? |
| Phenotype | 1 | 2019 | 4037 | 0.08 | Why? |
| Biomarkers, Tumor | 1 | 2016 | 1314 | 0.08 | Why? |
| Nucleic Acid Amplification Techniques | 1 | 2021 | 3388 | 0.08 | Why? |
| Trypsin | 1 | 2007 | 209 | 0.08 | Why? |
| Chloroquine | 1 | 2021 | 3152 | 0.08 | Why? |
| Communicable Diseases | 1 | 2021 | 2148 | 0.07 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.07 | Why? |
| Peptides | 1 | 2018 | 2513 | 0.07 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.07 | Why? |
| Health Services Needs and Demand | 1 | 2020 | 3419 | 0.07 | Why? |
| Binding Sites | 1 | 2018 | 6201 | 0.07 | Why? |
| Emergencies | 1 | 2020 | 4095 | 0.07 | Why? |
| Inflammation | 2 | 2017 | 13255 | 0.07 | Why? |
| Molecular Diagnostic Techniques | 1 | 2021 | 4239 | 0.07 | Why? |
| Middle Aged | 6 | 2018 | 270681 | 0.07 | Why? |
| Virus Diseases | 1 | 2021 | 3779 | 0.06 | Why? |
| Aged | 5 | 2018 | 215776 | 0.06 | Why? |
| Risk Factors | 4 | 2019 | 71621 | 0.06 | Why? |
| Peptidyl-Dipeptidase A | 2 | 2020 | 9659 | 0.06 | Why? |
| Virus Internalization | 1 | 2021 | 7921 | 0.06 | Why? |
| Protein Binding | 1 | 2018 | 11430 | 0.06 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.05 | Why? |
| Male | 6 | 2018 | 367725 | 0.05 | Why? |
| Hepatic Stellate Cells | 1 | 2020 | 35 | 0.05 | Why? |
| Cells, Cultured | 1 | 2011 | 5835 | 0.05 | Why? |
| Respiratory Tract Infections | 1 | 2021 | 6817 | 0.05 | Why? |
| Interdisciplinary Studies | 1 | 2020 | 95 | 0.05 | Why? |
| Acute Kidney Injury | 1 | 2020 | 5762 | 0.05 | Why? |
| Expectorants | 1 | 2020 | 95 | 0.05 | Why? |
| Viscosity | 1 | 2019 | 47 | 0.05 | Why? |
| Viral Vaccines | 1 | 2021 | 7560 | 0.05 | Why? |
| Elasticity | 1 | 2019 | 70 | 0.05 | Why? |
| Biomedical Research | 1 | 2020 | 5270 | 0.05 | Why? |
| Kidney Tubules, Proximal | 1 | 2020 | 178 | 0.05 | Why? |
| Porosity | 1 | 2019 | 185 | 0.05 | Why? |
| Drug Liberation | 1 | 2019 | 141 | 0.05 | Why? |
| Esters | 1 | 2021 | 300 | 0.05 | Why? |
| Serine Proteases | 1 | 2020 | 211 | 0.05 | Why? |
| Cytochrome P-450 CYP3A Inhibitors | 1 | 2020 | 256 | 0.05 | Why? |
| Oncolytic Viruses | 1 | 2017 | 20 | 0.04 | Why? |
| Anaphase-Promoting Complex-Cyclosome | 1 | 2017 | 2 | 0.04 | Why? |
| Cyclin B1 | 1 | 2017 | 7 | 0.04 | Why? |
| Homozygote | 1 | 2019 | 230 | 0.04 | Why? |
| Oxidative Stress | 1 | 2009 | 2050 | 0.04 | Why? |
| Oncolytic Virotherapy | 1 | 2017 | 36 | 0.04 | Why? |
| G2 Phase Cell Cycle Checkpoints | 1 | 2017 | 25 | 0.04 | Why? |
| HCT116 Cells | 1 | 2017 | 83 | 0.04 | Why? |
| Female | 6 | 2018 | 380317 | 0.04 | Why? |
| Embryonic Stem Cells | 1 | 2017 | 66 | 0.04 | Why? |
| Cathepsin L | 1 | 2021 | 566 | 0.04 | Why? |
| Heart Failure | 1 | 2018 | 6638 | 0.04 | Why? |
| Astrocytes | 1 | 2019 | 298 | 0.04 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.04 | Why? |
| Hepatocytes | 1 | 2020 | 549 | 0.04 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.04 | Why? |
| Guanidines | 1 | 2021 | 499 | 0.04 | Why? |
| Tumor Cells, Cultured | 1 | 2016 | 254 | 0.04 | Why? |
| Adult | 4 | 2018 | 244371 | 0.04 | Why? |
| Neoplasm Metastasis | 1 | 2019 | 682 | 0.04 | Why? |
| Cytokines | 1 | 2017 | 15010 | 0.04 | Why? |
| Gene Expression Regulation, Viral | 1 | 2020 | 925 | 0.03 | Why? |
| Aged, 80 and over | 2 | 2018 | 88759 | 0.03 | Why? |
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 347 | 0.03 | Why? |
| Young Adult | 2 | 2018 | 93724 | 0.03 | Why? |
| Open Reading Frames | 1 | 2020 | 1898 | 0.03 | Why? |
| Adolescent | 2 | 2018 | 86841 | 0.03 | Why? |
| History, 21st Century | 1 | 2020 | 1849 | 0.03 | Why? |
| Interdisciplinary Communication | 1 | 2020 | 1425 | 0.03 | Why? |
| Renal Dialysis | 1 | 2009 | 4358 | 0.03 | Why? |
| Neoplasm Recurrence, Local | 1 | 2019 | 1063 | 0.03 | Why? |
| Immune System | 1 | 2021 | 1479 | 0.03 | Why? |
| Transcription Factors | 1 | 2017 | 784 | 0.03 | Why? |
| Structure-Activity Relationship | 1 | 2017 | 2219 | 0.03 | Why? |
| Pandemics | 5 | 2020 | 389249 | 0.03 | Why? |
| Macaca mulatta | 1 | 2020 | 3716 | 0.03 | Why? |
| Protein Conformation | 1 | 2017 | 4386 | 0.02 | Why? |
| Myocardium | 1 | 2018 | 2323 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2020 | 7268 | 0.02 | Why? |
| Risk | 1 | 2019 | 5288 | 0.02 | Why? |
| Equipment Design | 1 | 2016 | 3095 | 0.02 | Why? |
| Survival Analysis | 1 | 2019 | 7592 | 0.02 | Why? |
| Liver | 1 | 2020 | 4007 | 0.02 | Why? |
| Serine Endopeptidases | 1 | 2021 | 4606 | 0.02 | Why? |
| Disease Models, Animal | 1 | 2020 | 10998 | 0.01 | Why? |
| Drug Repositioning | 1 | 2021 | 5683 | 0.01 | Why? |
| Clinical Trials as Topic | 1 | 2020 | 7330 | 0.01 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 9335 | 0.01 | Why? |
| Anti-Bacterial Agents | 1 | 2020 | 10083 | 0.01 | Why? |
| Genome, Viral | 1 | 2020 | 13157 | 0.01 | Why? |
| Child | 1 | 2007 | 70012 | 0.01 | Why? |
| Mutation | 1 | 2017 | 12376 | 0.01 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.01 | Why? |
| Public Health | 1 | 2020 | 16359 | 0.01 | Why? |
| China | 1 | 2021 | 50654 | 0.01 | Why? |
| Treatment Outcome | 1 | 2020 | 51732 | 0.01 | Why? |
| United States | 1 | 2020 | 46150 | 0.01 | Why? |
| RNA, Viral | 1 | 2020 | 32276 | 0.01 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2020 | 37182 | 0.01 | Why? |